Cargando…
SET domain-containing Protein 4 (SETD4) is a Newly Identified Cytosolic and Nuclear Lysine Methyltransferase involved in Breast Cancer Cell Proliferation
Cancer is comprised of a multitude of epigenetic abnormalities, including the global loss and regional gain of DNA methylation as well as alterations in histone methylation. Here, we characterize a new methyltransferase, SET domain-containing protein 4 (SETD4), which is involved in breast carcinogen...
Autores principales: | Faria, Jerusa Araújo Quintão Arantes, Corrêa, Natássia Caroline Resende, de Andrade, Carolina, de Angelis Campos, Ana Carolina, dos Santos Samuel de Almeida, Rubens, Rodrigues, Thiago Souza, de Goes, Alfredo Miranda, Gomes, Dawidson Assis, Silva, Fábio Pittella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984760/ https://www.ncbi.nlm.nih.gov/pubmed/24738023 |
Ejemplares similares
-
Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
por: Melo, Carolina Soares Barros, et al.
Publicado: (2013) -
Structure, activity and function of the lysine methyltransferase SETD5
por: Li, Mingyang, et al.
Publicado: (2023) -
Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
por: Binda, Olivier
Publicado: (2019) -
The emerging role of lysine methyltransferase SETD8 in human diseases
por: Milite, Ciro, et al.
Publicado: (2016) -
The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase
por: Seervai, Riyad N. H., et al.
Publicado: (2020)